Status:
UNKNOWN
Psychometric Properties of the Chinese Version of PeNAT
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Cancer
Child
Eligibility:
All Genders
4-17 years
Brief Summary
Cancer is a leading cause of death for children. Chemotherapy is the most common treatment for cancer. Notwithstanding the improved survival, children with cancer still have to face a significant amou...
Detailed Description
Currently, the most effective anti-emetics appear to be 5-HT3 inhibitors, followed by NK1 inhibitors and neuroleptic drugs. Nevertheless, anti-emetics alone are not sufficient to manage these two symp...
Eligibility Criteria
Inclusion
- Aged 4 - 17
- A confirmed diagnosis of cancer
- Currently undergoing chemotherapy
- Able to speak Cantonese and read Chinese
Exclusion
- Cognitive or behavioral problems in medical records
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04827108
Start Date
September 1 2022
End Date
August 31 2024
Last Update
March 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.